NewLink Genetics Reports First Quarter 2019 Financial Results and Provides Clinical Activities Update

NEXT STORY
Ziopharm Oncology Reports First Quarter 2019 Financial Results and Reaffirms Clinical Timelines
PREV STORY
T2 Biosystems to Showcase Breakthrough Rapid Diagnostics During 22nd Annual MAD-ID Meeting in Orlando, Florida
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

The fluoroscopy equipment market is projected to reach USD 7.11 billion by 2024 from USD 5.75 billion in 2019, at a CAGR of 4.4%

author_avatar
NASDAQ Market News

Stemline Therapeutics Highlights Recent Clinical and Regulatory Developments and Details Upcoming Milestones following its Annual Shareholder Meeting

author_avatar
NASDAQ Market News

Foghorn Therapeutics Provides Second Quarter 2021 Corporate Update

author_avatar
NASDAQ Market News